These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33822920)

  • 1. Quality-by-Design Approach for Chromatographic Analysis of Metformin, Empagliflozin and Linagliptin.
    Gurrala S; Raj S; Cvs S; Anumolu PD
    J Chromatogr Sci; 2022 Jan; 60(1):68-80. PubMed ID: 33822920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of experimental design in HPLC method optimization and robustness for the simultaneous determination of canagliflozin, empagliflozin, linagliptin, and metformin in tablet.
    Moussa BA; Mahrouse MA; Fawzy MG
    Biomed Chromatogr; 2021 Oct; 35(10):e5155. PubMed ID: 33949720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid LC-PDA method for the simultaneous quantification of metformin, empagliflozin and linagliptin in pharmaceutical dosage form.
    Gollu G; Gummadi S
    Ann Pharm Fr; 2022 Jan; 80(1):48-58. PubMed ID: 34157314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of linagliptin and empagliflozin by UPLC and HPTLC techniques aided by lean six sigma approach.
    El-Desouky EA; Abdel-Raoof AM; Abdel-Fattah A; Abdel-Zaher A; Osman AOE; Abdel-Monem AH; Morshedy S
    Biomed Chromatogr; 2021 Jul; 35(7):e5102. PubMed ID: 33629452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-indicating ultra performance liquid chromatography method development and validation for simultaneous estimation of metformin, linagliptin, and empagliflozin in bulk and pharmaceutical dosage form.
    Vankalapati KR; Alegete P; Boodida S
    Biomed Chromatogr; 2021 Apr; 35(4):e5019. PubMed ID: 33146442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of linagliptin and metformin by reverse phase-high performance liquid chromatography method: An application in quantitative analysis of pharmaceutical dosage forms.
    Vemula P; Dodda D; Balekari U; Panga S; Veeresham C
    J Adv Pharm Technol Res; 2015; 6(1):25-8. PubMed ID: 25709966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated Liquid Chromatographic Method for the Determination of (Canagliflozin, Dapagliflozin or Empagliflozin) and Metformin in the Presence of (1-Cyanoguanidine).
    Hassib ST; Taha EA; Elkady EF; Barakat GH
    J Chromatogr Sci; 2019 Aug; 57(8):697-707. PubMed ID: 31240304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a novel UPLC-MS/MS method for estimation of metformin and empagliflozin simultaneously in human plasma using freezing lipid precipitation approach and its application to pharmacokinetic study.
    Abou-Omar MN; Kenawy M; Youssef AO; Alharthi S; Attia MS; Mohamed EH
    J Pharm Biomed Anal; 2021 Jun; 200():114078. PubMed ID: 33901756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DoE-Based Analytical Failure Modes Critical Effect Analysis (AFMCEA) to a Multipurpose-RP-HPLC Method for the Estimation of Multiple FDC Products of Metformin Hydrochloride Using an Analytical Quality by Design Approach.
    Prajapati PB; Mistry KY; Shah SA
    J AOAC Int; 2022 Jun; 105(4):986-998. PubMed ID: 35176154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride using High Performance Liquid Chromatography.
    El-Bagary RI; Elkady EF; Ayoub BM
    Int J Biomed Sci; 2013 Mar; 9(1):41-7. PubMed ID: 23675288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS Determination of Empagliflozin and Metformin.
    Ayoub BM; Mowaka S
    J Chromatogr Sci; 2017 Aug; 55(7):742-747. PubMed ID: 28383657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability kinetics of fusidic acid: Development and validation of stability indicating analytical method by employing Analytical Quality by Design approach in medicinal product(s).
    Sharma G; Thakur K; Raza K; Katare OP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():113-124. PubMed ID: 31082718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QbD-steered development and validation of an RP-HPLC method for quantification of ferulic acid: Rational application of chemometric tools.
    Saini S; Sharma T; Patel A; Kaur R; Tripathi SK; Katare OP; Singh B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122300. PubMed ID: 32771967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography-mass spectrometry and application to pharmacokinetics.
    Wattamwar T; Mungantiwar A; Halde S; Pandita N
    Eur J Mass Spectrom (Chichester); 2020 Apr; 26(2):117-130. PubMed ID: 31575298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide.
    Gedawy A; Al-Salami H; Dass CR
    J Food Drug Anal; 2019 Jan; 27(1):315-322. PubMed ID: 30648585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exquisite integration of quality-by-design and green analytical approaches for simultaneous determination of xylometazoline and antazoline in eye drops and rabbit aqueous humor, application to stability study.
    Hussein OG; Ahmed DA; Rezk MR; Abdelkawy M; Rostom Y
    J Pharm Biomed Anal; 2023 Oct; 235():115598. PubMed ID: 37516064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in simultaneous extraction and chromatographic separation of metformin and three SGLT-2 inhibitors in human plasma using LC-MS/MS.
    Shah PA; Shrivastav PS; Sharma V; Yadav MS
    J Pharm Biomed Anal; 2019 Oct; 175():112790. PubMed ID: 31362250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method.
    Elmasry MS; Hassan WS; Merey HA; Nour IM
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jun; 254():119609. PubMed ID: 33684852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
    Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
    Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC.
    Sha'at M; Spac AF; Stoleriu I; Bujor A; Cretan MS; Hartan M; Ochiuz L
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.